ANGIODYNAMICS INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AngioDynamics, Inc. on May 11, 2009, covering events occurring on May 8, 2009, and May 11, 2009. The filing addresses changes in the company's Board of Directors and related compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial figure disclosed is a specific compensatory payment:
- Compensatory Advance: $200,000 paid to Eamonn P. Hobbs against amounts owed under his employment agreement.
Material Changes
The following material changes regarding corporate governance and personnel were reported:
- Director Resignation: Eamonn P. Hobbs resigned from the Board of Directors effective May 8, 2009. The resignation was not the result of any disagreement with the company.
- Director Appointment: Jan Keltjens, President and CEO, was appointed to the Board of Directors on May 11, 2009, to fill the vacancy created by Mr. Hobbs. His term expires at the 2009 annual meeting.
- Compensation Agreement: The Board agreed to pay Mr. Hobbs the $200,000 advance pursuant to Section 7 of his employment agreement dated January 20, 2009.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies were disclosed in this report, other than the standard disclosure that the press release attached as Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the terms of the employment agreement between AngioDynamics and Eamonn P. Hobbs (filed as Exhibit 10.5 to the January 23, 2009 8-K) to understand the full scope of the $200,000 advance.
- Review the press release dated May 11, 2009 (Exhibit 99.1) for additional context on the Board appointment.
- Confirm the status of Jan Keltjens' dual role as President, CEO, and newly appointed Director.